Guidelines for the Postoperative Treatment of Thyroid Cancer: Levothyroxine and Calcium/Vitamin D Supplements.
10.3904/kjm.2017.92.3.245
- Author:
Jeonghoon HA
1
;
Dong Jun LIM
Author Information
1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. ldj6026@catholic.ac.kr
- Publication Type:Review
- Keywords:
Thyroid cancer;
Hypoparathyroidism;
Calcium;
Vitamin D
- MeSH:
Calcium;
Cardiovascular Diseases;
Hypocalcemia;
Hypoparathyroidism;
Hypothyroidism;
Osteoporosis;
Prescriptions;
Recurrence;
Reference Values;
Risk Factors;
Thyroid Gland*;
Thyroid Neoplasms*;
Thyrotropin;
Thyroxine*;
Vitamin D
- From:Korean Journal of Medicine
2017;92(3):245-250
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Thyroid hormone replacement is required after surgery for thyroid cancer to manage postoperative hypothyroidism and for thyroid-stimulating hormone (TSH) suppression therapy. However, considering the increased risks of cardiovascular disease and osteoporosis as a result of excessive thyroid hormone administration, it is necessary to maintain the correct dose. This requires prescription strategies tailored to the patient's individual TSH goals by assessing the risk of recurrence, response to treatment, and risk factors for thyroid hormone therapy. In addition, if hypocalcemia is observed or symptoms of hypocalcemia are detected postoperatively, calcium and vitamin D should be administered to improve the symptoms and maintain serum calcium levels within normal ranges.
